INC Research Holdings, Inc. (INCR) Receives Average Recommendation of “Hold” from Analysts
INC Research Holdings, Inc. (NASDAQ:INCR) has been assigned an average rating of “Hold” from the thirteen brokerages that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $52.00.
Several equities analysts recently weighed in on INCR shares. TheStreet upgraded INC Research from a “c” rating to a “b-” rating in a research report on Monday, November 6th. Robert W. Baird set a $46.00 target price on INC Research and gave the stock a “buy” rating in a research report on Thursday, November 16th. Jefferies Group reiterated a “buy” rating and set a $55.00 target price on shares of INC Research in a research report on Friday, November 10th. Zacks Investment Research upgraded INC Research from a “hold” rating to a “buy” rating and set a $58.00 target price on the stock in a research report on Wednesday, September 27th. Finally, SunTrust Banks reduced their target price on INC Research to $50.00 and set a “buy” rating on the stock in a research report on Friday, December 1st.
Shares of INC Research (INCR) traded up $1.35 during trading hours on Thursday, hitting $39.30. The stock had a trading volume of 842,887 shares, compared to its average volume of 928,713. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.27 and a quick ratio of 1.27. INC Research has a twelve month low of $33.60 and a twelve month high of $61.10. The stock has a market capitalization of $3,980.76, a P/E ratio of 17.50, a P/E/G ratio of 1.20 and a beta of 1.08.
In other INC Research news, CEO Alistair Macdonald sold 2,348 shares of the company’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $54.60, for a total transaction of $128,200.80. Following the completion of the sale, the chief executive officer now directly owns 99,453 shares in the company, valued at $5,430,133.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Gregory S. Rush sold 9,703 shares of the company’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $54.48, for a total value of $528,619.44. Following the sale, the chief financial officer now owns 78,593 shares of the company’s stock, valued at $4,281,746.64. The disclosure for this sale can be found here. Insiders have sold 16,733 shares of company stock valued at $912,270 over the last 90 days. 0.24% of the stock is currently owned by insiders.
A number of large investors have recently made changes to their positions in the business. Lee Thomas H Partners LP acquired a new stake in INC Research during the third quarter worth about $1,316,644,000. BlackRock Inc. increased its stake in INC Research by 82.3% during the second quarter. BlackRock Inc. now owns 6,461,899 shares of the company’s stock worth $378,020,000 after acquiring an additional 2,917,605 shares during the last quarter. Vanguard Group Inc. increased its stake in INC Research by 2.4% during the second quarter. Vanguard Group Inc. now owns 6,186,393 shares of the company’s stock worth $361,904,000 after acquiring an additional 142,349 shares during the last quarter. State Street Corp increased its stake in INC Research by 112.8% during the second quarter. State Street Corp now owns 1,769,353 shares of the company’s stock worth $103,508,000 after acquiring an additional 937,864 shares during the last quarter. Finally, Janus Henderson Group PLC acquired a new stake in INC Research during the second quarter worth about $99,424,000. Institutional investors own 99.56% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/12/07/inc-research-holdings-inc-incr-receives-average-recommendation-of-hold-from-analysts.html.
About INC Research
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.